Back to search results

Walking Exercise Program for Stroke Survivors

This study is testing a walking exercise program for people who have had a stroke and are currently unable to walk independently. The main goal is to see if this gait (walking) training, which uses a treadmill with partial body-weight support and a special device, can improve your heart health better than a sitting leg cycling exercise. Researchers will measure changes in your resting heart rate, systolic blood pressure (SBP), and A1c levels (a measure of blood sugar) after 8 weeks. You might be able to join if you are 18-80 years old, had your first stroke at least 6 months ago, and can understand English commands. The study is looking for 72 participants.

Study design
This is an interventional study planning to enroll 72 participants. It compares a gait training program with a leg cycling exercise.
What's involved
Participants will undergo an 8-week intervention program. Assessments will be done at the beginning and at the end of the 8-week intervention.
Compensation
Not stated in the trial record.
Follow-up
Participants will be assessed at baseline and at the end of the 8-week intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06247553

To Develop a Walking Exercise Program for Non-ambulatory Stroke Survivors

Recruiting
NAAges 18–80InterventionalSupportive care
University of Kansas Medical Center
~72 participants
Updated 2025-08-01 on ClinicalTrials.gov
What's tested:Gait TrainingLeg Cycling Exercise

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
changes in resting heart rate (rHR)
Measured over All participants will be assessed at baseline (during the evaluation) and at the end of the 8-week intervention.
+2 more outcomes measured

Conditions

Stroke
Walking, Difficulty
Cardiovascular Injury

Explore related trials

Stroke

NCT06247553

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • University of Kansas Medical Center

    Kansas City, Kansasstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Wen Liu, PhD · PRINCIPAL_INVESTIGATOR · University of Kansas Medical Center

Who to contact

Carrie Bailey, MA
[email protected]
402-709-8841
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

must be 18 to 80 years old
male or female
independent ambulation before stroke
able to understand and follow verbal commands in English
have physicians' approval for exercise
be in a stable medical condition
must be after the first stroke
unable to walk independently
in the chronic stage (at least 6 months after stroke onset)

Exclusion

musculoskeletal or other disorders that prevent the participant from participating in the exercise
blood pressure higher than 200/110 mm Hg
diagnosis of severe depression
functionally restricted passive movement in the major joints of lower limbs
unable to speak or understand English
unable to travel to the Research Laboratory
currently participate in other walking training using treadmill with or without a body-weight support system
body weight greater than 400 lbs

What this trial measures

  • changes in resting heart rate (rHR)All participants will be assessed at baseline (during the evaluation) and at the end of the 8-week intervention.

    Resting heart rate (measured in beats per minute) will be measured using a Polar heart rate monitoring system.

  • systolic blood pressure (SBP)All participants will be assessed at baseline (during the evaluation) and at the end of the 8-week intervention.

    Systolic blood pressure (measured in mmHg) will be measured using a mercury sphygmomanometer.

  • glycated hemoglobin (HbA1c)All participants will be assessed at baseline (during the evaluation) and at the end of the 8-week intervention.

    HbA1c levels will be measured by collecting a drop of blood from the middle finger of the unaffected hand and use the A1CNow+ System for analysis.